Haleon PLC Sponsored ADR (HLN) vs Viatris Inc. (VTRS)

Haleon PLC Sponsored ADR and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Haleon PLC Sponsored ADR is the larger, with a market value of $43.7B against $20.9B — 2.1× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Haleon PLC Sponsored ADR trades at 22.6×. Haleon PLC Sponsored ADR has the higher net margin (13.8% vs −2.79%) and the higher return on invested capital (0.00% vs −0.20%). Both pay a dividend; Viatris Inc. yields more (2.57% vs 1.95%). Across the 21 metrics below, Haleon PLC Sponsored ADR leads on 13 and Viatris Inc. on 8.

Valuation

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
P/E 22.58 n/m 19.25
P/S 2.57 1.47 2.11
P/B 2.11 1.52 1.78
Price to free cash flow 10.24 11.48 16.14
EV/EBITDA 13.30 12.58 12.58
EV/Sales 3.12 2.32 2.73
Earnings yield 4.43% (1.93%) (4.38%)
Free cash flow yield 9.77% 8.71% 0.00%

Profitability

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Gross margin 62.22% 34.83% 53.94%
Operating margin 17.93% (0.59%) 0.00%
Net margin 13.79% (2.79%) 0.00%
Free cash flow margin 0.00% 12.83% 0.00%
Return on equity 0.00% (2.75%) (0.40%)
Return on assets 0.00% (1.12%) (3.32%)
Return on invested capital 0.00% (0.20%) 0.00%

Growth

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 4.40% 10.01%
EPS growth (last fiscal year) 22.50% (466.04%) 49.06%
Revenue growth, 5-year CAGR 1.43% 3.66% 6.74%
Net income growth, 5-year CAGR 6.98% 0.00% 0.00%

Health

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.94 0.05
Current ratio 0.69 1.58 2.31
Net debt to EBITDA 2.63 4.92 0.97

Dividend

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Dividend yield 1.95% 2.57% 1.57%
Payout ratio — — 0.27

Size

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Market cap 43.71b 20.93b 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack